Atlas FDA

OPUS(R) CEA TEST SYSTEM

FDA premarket approval P920021/S001 · decided 1996-02-23

Approval details

PMA number
P920021
Supplement
S001
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
OPUS(R) CEA TEST SYSTEM
Generic name
SYSTEM, TEST, CARCINOEMBRYONIC ANTIGEN
Applicant
Behring Diagnostics, Inc.
Date received
1995-07-03
Decision date
1996-02-23
Days to decision
235 days
Decision code
APPR
Product code
DHX
Advisory committee
Immunology
Expedited review
No
Location
Westwood, MA
Statement
APPROVAL TO ADD THE CEA TEST SYSTEM TO THE OPUS PLUS AND OPUS MAGNUM ANALYZERS. THE SAME TEST SYSTEM IS USED ON ALL THREE INSTRUMENTS

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
OPUS HLH CONTROLS (K973832)Behring Diagnostics, Inc.1997-10-27
N ANTISERUM TO HUMAN ALBUMIN (K972929)Behring Diagnostics, Inc.1997-10-20
N ANTISERUM TO HUMAN TRANSFERRIN (K972840)Behring Diagnostics, Inc.1997-10-17
MODIFICATION OF OPUS FERRITIN TEST SYSTEM (K973202)Behring Diagnostics, Inc.1997-09-12
OPUS D-DIMER (K972316)Behring Diagnostics, Inc.1997-09-09
VON WILLEBRAND REAGENT (K972116)Behring Diagnostics, Inc.1997-07-25
OPUS ETHANOL (K972011)Behring Diagnostics, Inc.1997-07-22
EMIT CALIBRATOR B LEVEL 1 (CUTOFF)/EMIT CALIBRATOR B LEVEL 2 (HIGH) (K971600)Behring Diagnostics, Inc.1997-06-25